Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study

[1]  M. Schulze,et al.  Odd-chain fatty acids as a biomarker for dietary fiber intake: a novel pathway for endogenous production from propionate. , 2017, The American journal of clinical nutrition.

[2]  R. Krauss,et al.  Odd Chain Fatty Acids; New Insights of the Relationship Between the Gut Microbiota, Dietary Intake, Biosynthesis and Glucose Intolerance , 2017, Scientific Reports.

[3]  B. Heit,et al.  Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis. , 2015, American journal of physiology. Endocrinology and metabolism.

[4]  M. Schulze,et al.  Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study , 2015, PloS one.

[5]  D. Mozaffarian,et al.  Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. , 2015, The American journal of clinical nutrition.

[6]  D. Mozaffarian,et al.  Prospective association of fatty acids in the de novo lipogenesis pathway with risk of type 2 diabetes: the Cardiovascular Health Study. , 2015, The American journal of clinical nutrition.

[7]  Elisa T. Lee,et al.  The Strong Heart Study , 2015 .

[8]  M. Rewers,et al.  Serum pentadecanoic acid (15:0), a short-term marker of dairy food intake, is inversely associated with incident type 2 diabetes and its underlying disorders. , 2014, The American journal of clinical nutrition.

[9]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.

[10]  H. Kalbacher,et al.  De novo lipogenesis in health and disease. , 2014, Metabolism: Clinical and Experimental.

[11]  D. Mozaffarian,et al.  Plasma Phospholipid Saturated Fatty Acids and Incident Atrial Fibrillation: The Cardiovascular Health Study , 2014, Journal of the American Heart Association.

[12]  Simon G Thompson,et al.  Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. , 2014, Annals of internal medicine.

[13]  R. Lamuela-Raventós,et al.  Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease. , 2014, Clinical nutrition.

[14]  M. Laakso,et al.  Association of erythrocyte membrane fatty acids with changes in glycemia and risk of type 2 diabetes. , 2014, The American journal of clinical nutrition.

[15]  M. Schulze,et al.  Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study , 2014, European Journal of Clinical Nutrition.

[16]  R. Glynn,et al.  Plasma phospholipid saturated fatty acids and heart failure risk in the Physicians' Health Study. , 2013, Clinical nutrition.

[17]  Qi Sun,et al.  Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. , 2013, The American journal of clinical nutrition.

[18]  D. Mozaffarian,et al.  Biomarkers of Dairy Fatty Acids and Risk of Cardiovascular Disease in the Multi‐Ethnic Study of Atherosclerosis , 2013, Journal of the American Heart Association.

[19]  N. Forouhi,et al.  Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies , 2013, Genome Medicine.

[20]  K. Fukao,et al.  High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. , 2013, Diabetes research and clinical practice.

[21]  S. Yi,et al.  High levels of stearic acid, palmitoleic acid, and dihomo-γ-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance. , 2012, Nutrition research.

[22]  E. Riboli,et al.  Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective Study , 2012, PLoS medicine.

[23]  Gerd Geisslinger,et al.  Chain length-specific properties of ceramides. , 2012, Progress in lipid research.

[24]  N Slimani,et al.  Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study , 2011, Diabetologia.

[25]  Moshe Levi,et al.  Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. , 2011, Circulation.

[26]  B. Howard,et al.  Individual saturated fatty acids are associated with different components of insulin resistance and glucose metabolism: the GOCADAN study , 2010, International journal of circumpolar health.

[27]  G. Hallmans,et al.  Biomarkers of milk fat and the risk of myocardial infarction in men and women: a prospective, matched case-control study. , 2010, The American journal of clinical nutrition.

[28]  Sabine Borwege,et al.  Nutrient Modification of the Innate Immune Response: A Novel Mechanism by Which Saturated Fatty Acids Greatly Amplify Monocyte Inflammation , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[29]  J. Árnlöv,et al.  Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men. , 2010, Diabetes research and clinical practice.

[30]  S. Klein,et al.  Pathogenesis and Pathophysiology of the Cardiometabolic Syndrome , 2009, Journal of clinical hypertension.

[31]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[32]  Sangyeoup Lee,et al.  n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: a case–control study in Korea , 2008, British Journal of Nutrition.

[33]  Steven Hawken,et al.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study , 2008, The Lancet.

[34]  N Slimani,et al.  The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study , 2007, European Journal of Clinical Nutrition.

[35]  Y. Aggoun,et al.  Obesity, Metabolic Syndrome, and Cardiovascular Disease , 2007, Pediatric Research.

[36]  D. Capuzzi,et al.  C-Reactive Protein and Cardiovascular Risk in the Metabolic Syndrome and Type 2 Diabetes: Controversy and Challenge , 2007 .

[37]  J. Li,et al.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix , 2005, Heredity.

[38]  S. Yusuf,et al.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.

[39]  E. Schleicher,et al.  Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB* , 2004, Journal of Biological Chemistry.

[40]  L. Weinehall,et al.  Estimated intake of milk fat is negatively associated with cardiovascular risk factors and does not increase the risk of a first acute myocardial infarction. A prospective case–control study , 2004, British Journal of Nutrition.

[41]  J. Pankow,et al.  Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2003, The American journal of clinical nutrition.

[42]  A. Gotto.  High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. , 2002, American heart journal.

[43]  N E Day,et al.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection , 2002, Public Health Nutrition.

[44]  J. Rood,et al.  Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. , 2001, Metabolism: clinical and experimental.

[45]  B. Howard,et al.  LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[46]  M. Hellerstein,et al.  De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. , 1999, The American journal of clinical nutrition.

[47]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.